[Disturbances in folate metabolism during anticonvulsant treatments. Possible role of a decrease of tetrahydrofolate conversion to N5 methyl THF].
D000748:Anemia, Macrocytic / Q000139:chemically induced; D000927:Anticonvulsants / Q000009:adverse effects*; D004827:Epilepsy / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects; D008297:Male; D008862:Microsomes, Liver / Q000187:drug effects / Q000378:metabolism; D010634:Phenobarbital / Q000009:adverse effects; D010672:Phenytoin / Q000009:adverse effects; D011324:Primidone / Q000009:adverse effects; D012737:Sex Factors; D013329:Structure-Activity Relationship; D013763:Tetrahydrofolates / Q000097:blood / Q000134:cerebrospinal fluid / Q000378:metabolism*
D000927:Anticonvulsants; D013763:Tetrahydrofolates; D011324:Primidone; D010672:Phenytoin; D010634:Phenobarbital
Perturbations du métabolisme des folates au cours des traitements anticonvulsivants. Rôle éventuel d'une diminution de la conversion des tétrahydrofolates en N5 méthyl THF